Table of Contents
Pathology Research International
Volume 2014, Article ID 179384, 5 pages
http://dx.doi.org/10.1155/2014/179384
Research Article

Hospital-Based Study of Epithelial Malignancies of Endometrial Cancer Frequency in Lahore, Pakistan, and Common Diagnostic Pitfalls

1Fatima Memorial College of Medicine and Dentistry, Lahore 54000, Pakistan
2Department of Biomedical Sciences, King Edward Medical University, Lahore 54000, Pakistan

Received 29 October 2013; Accepted 11 December 2013; Published 6 January 2014

Academic Editor: Shahid Pervez

Copyright © 2014 Imrana Tanvir et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Hecht and G. L. Mutter, “Molecular and pathologic aspects of endometrial carcinogenesis,” Journal of Clinical Oncology, vol. 24, no. 29, pp. 4783–4791, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Balasubramaniam, S. Sushama, B. Rasika, and U. Mahantshetty, “Hospital-based study of endometrial cancer survival in Mumbai, India,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 2, pp. 977–980, 2013. View at Publisher · View at Google Scholar
  3. P. G. Rose, “Endometrial carcinoma,” New England Journal of Medicine, vol. 335, no. 9, pp. 640–649, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Prat, A. Gallardo, M. Cuatrecasas, and L. Catasús, “Endometrial carcinoma: pathology and genetics,” Pathology, vol. 39, no. 1, pp. 72–87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Shu, S. Fang, P. G. Teichman, L. Xing, and H. Huang, “Endometrial carcinoma tumorigenesis and pharmacotherapy research,” Minerva Endocrinologica, vol. 37, no. 2, pp. 117–132, 2012. View at Google Scholar
  6. B. Dobrzycka and S. J. Terlikowski, “Biomarkers as prognostic factors in endometrial cancer,” Folia Histochemica et Cytobiologica, vol. 48, no. 3, pp. 319–322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Arafa, J. Somja, P. Dehan et al., “Current concepts in the pathology and epigenetics of endometrial carcinoma,” Pathology, vol. 42, no. 7, pp. 613–617, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. C. E. Platz and J. A. Benda, “Female genital tract cancer,” Cancer, vol. 75, supplement 1, pp. 270–294, 1995. View at Google Scholar · View at Scopus
  9. D. G. Gallup and R. J. Stock, “Adenocarcinoma of the endometrium in women 40 years of age or younger,” Obstetrics and Gynecology, vol. 64, no. 3, pp. 417–420, 1984. View at Google Scholar · View at Scopus
  10. M. E. Sherman, “Theories of endometrial carcinogenesis: a multidisciplinary approach,” Modern Pathology, vol. 13, no. 3, pp. 295–308, 2000. View at Google Scholar · View at Scopus
  11. A. Di Cristofano and L. H. Ellenson, “Endometrial carcinoma,” Annual Review of Pathology, vol. 2, pp. 57–85, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Azueta, S. Gatius, and X. Matias-Guiu, “Endometrioid carcinoma of the endometrium: pathologic and molecular features,” Seminars in Diagnostic Pathology, vol. 27, no. 4, pp. 226–240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. V. Bokhman, “Two pathogenetic types of endometrial carcinoma,” Gynecologic Oncology, vol. 15, no. 1, pp. 10–17, 1983. View at Google Scholar · View at Scopus
  14. S. G. Silverberg, “Problems in the differential diagnosis of endometrial hyperplasia and carcinoma,” Modern Pathology, vol. 13, no. 3, pp. 309–327, 2000. View at Google Scholar · View at Scopus
  15. R. J. Zaino, R. Kurman, D. Herbold et al., “The significance of squamous differentiation in endometrial carcinoma: data from a Gynecologic Oncology Group study,” Cancer, vol. 68, no. 10, pp. 2293–2302, 1991. View at Google Scholar · View at Scopus
  16. S. B. Gusberg, “Virulence factors in endometrial cancer,” Cancer, vol. 71, supplement 4, pp. 1464–1466, 1993. View at Google Scholar · View at Scopus
  17. B. A. Clarke and C. B. Gilks, “Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type,” Journal of Clinical Pathology, vol. 63, no. 5, pp. 410–415, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. R. Nucci, D. H. Castrillon, H. Bai et al., “Biomarkers in diagnostic obstetric and gynecologic pathology: a review,” Advances in Anatomic Pathology, vol. 10, no. 2, pp. 55–68, 2003. View at Publisher · View at Google Scholar
  19. “Declaration of Helsinki. Ethical principles for medical research involving human subjects,” Journal of the Indian Medical Association, vol. 107, no. 6, pp. 403–405, 2009.
  20. J. Fanning, M. C. Evans, A. J. Peters, M. Samuel, E. R. Harmon, and J. S. Bates, “Endometrial adenocarcinoma histologic subtypes: clinical and pathologic profile,” Gynecologic Oncology, vol. 32, no. 3, pp. 288–291, 1989. View at Google Scholar · View at Scopus
  21. W. T. Creasman, F. Odicino, P. Maisonneuve et al., “Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer,” International Journal of Gynecology & Obstetrics, vol. 95, supplement 1, pp. S105–S143, 2006. View at Publisher · View at Google Scholar
  22. W. M. Christopherson, R. C. Alberhasky, and P. J. Connelly, “Carcinoma of the endometrium. II. Papillary adenocarcinoma: a clinical pathological study 46 cases,” American Journal of Clinical Pathology, vol. 77, no. 5, pp. 534–540, 1982. View at Google Scholar · View at Scopus
  23. W. Bocker, “WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics,” Verhandlungen der Deutschen Gesellschaft für Pathologie, vol. 86, pp. 116–119, 2002. View at Google Scholar
  24. P. B. Clement and R. H. Young, “Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects,” Advances in Anatomic Pathology, vol. 9, no. 3, pp. 145–184, 2002. View at Google Scholar · View at Scopus
  25. R. A. Ambros, F. Ballouk, J. H. Malfetano, and J. S. Ross, “Significance of papillary (villoglandular) differentiation in endometrioid carcinoma of the uterus,” American Journal of Surgical Pathology, vol. 18, no. 6, pp. 569–575, 1994. View at Google Scholar · View at Scopus
  26. F. Darvishian, A. J. Hummer, H. T. Thaler et al., “Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases,” American Journal of Surgical Pathology, vol. 28, no. 12, pp. 1568–1578, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Zheng, R. Khurana, S. Farahmand, Y. Wang, Z. Zhang, and J. C. Felix, “p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma,” American Journal of Surgical Pathology, vol. 22, no. 12, pp. 1463–1473, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. S. K. Murray, R. H. Young, and R. E. Scully, “Uterine endometrioid carcinoma with small nonvillous papillae: an analysis of 26 cases of a favorable-prognosis tumor to be distinguished from serous carcinoma,” International Journal of Surgical Pathology, vol. 8, no. 4, pp. 279–289, 2000. View at Google Scholar · View at Scopus
  29. B. Djordjevic, S. Westin, and R. R. Broaddus, “Application of immunohistochemistry and molecular diagnostics to clinically relevant problems in endometrial cancer,” Surgical Pathology Clinics, vol. 5, no. 4, pp. 859–878, 2012. View at Publisher · View at Google Scholar